The gastrointestinal adverse events associated with GLP-1 receptor agonists are typically dose-dependent, transient, and manageable with slow titration (Meier, Diabetes, Obesity and Metabolism )
The initial response at 2.5 mg often diminishes over time, making escalation necessary to maintain efficacy
State Legislative Landscape in 2025 Despite a significant number of bills in 2023 and 2024 that would have required mandated coverage of GLP-1s in Medicaid, state employee health plans, or for health insurers regulated by the state, only Arkansas, California, Maryland, New Mexico, Pennsylvania, and Texas have introduced legislation mandating coverage in 2025 to date
They may not believe in using unconventional treatments, or dont agree with using traditionally accepted medications in novel ways
It is available in a generic formulation under different brand names, including Inderal